PG - The Procter & Gamble Company
| Previous Close | 74.95 |
| Open | 74.04 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 73.74 - 74.92 |
| 52 Week Range | 73.74 - 94.67 |
| Volume | 14,084,970 |
| Avg. Volume | 10,663,338 |
| Market Cap | 186.05B |
| Beta | 0.38 |
| PE Ratio (TTM) | 19.69 |
| EPS (TTM) | 3.75 |
| Earnings Date | Apr 24, 2018 - Apr 30, 2018 |
| Forward Dividend & Yield | 2.87 (3.65%) |
| Ex-Dividend Date | 2018-04-19 |
| 1y Target Est | 90.65 |
Yahoo Finance Video•15 hours agoBusiness + Coffee: Trump and oil prices, P&G and YouTube ads, Lance Armstrong settles
Friday, April 20: Trump is angry at OPEC over oil prices; P&G brands return to advertising with YouTube after a year off; Lance Armstrong settles fraud lawsuit with government for $5 million. Yahoo Finance’s Dan Roberts dives in.
- Barrons.com•10 hours ago
Consumer Staples Had a Terrible, Horrible, No Good, Very Bad Week
The Consumer Staples Select Sector SPDR ETF (XLP)—a basket of 34 companies in the sector—lost almost 3% Thursday, largely caused by the 16% drop in tobacco giant Philip Morris (PM), after its cigarette shipments fell more than expected and its heated-tobacco product—an area with high expectations for rapid growth—was experiencing headwinds in key market Japan. The company cited higher commodities and transportation costs as the cause of narrower margins, and admitted sales growth "has been challenging in a very difficult market environment." These three companies collectively comprise approximately 25% of the consumer-staples sector, which helps explain why the Consumer Staples ETF dropped 4.1% last week. It's no secret that Amazon.com (AMZN) and Walmart (WMT) have essentially made the retail space an oligopoly, says Mike O’Rourke, chief market strategist of JonesTrading.
Market Realist•13 hours agoProcter & Gamble’s 3Q Sales Improved, but Challenges Persist
Procter & Gamble (PG) reported net sales of $16.3 billion, a rise of 4.3% YoY (year-over-year), which exceeded analysts’ expectations. As expected, Procter & Gamble’s top line benefitted from improved volumes and favorable currency rates. Also, the improved mix contributed 1% to the net sales growth rate.
- Market Realist•14 hours ago
Why Procter & Gamble’s Fiscal 3Q18 EPS Didn’t Impress Investors
Procter & Gamble (PG) reported adjusted earnings of $1.00 per share in fiscal 3Q18, which came in ahead of analysts’ estimate of $0.98 and increased 4.2% YoY (year-over-year). Moreover, Procter & Gamble has now surpassed analysts’ earnings expectations in the past 12 quarters. However, what didn’t sit well with investors was the company’s low EPS growth rate, especially given the benefits from favorable currency rates, the low tax rate environment, and strong productivity savings.
- Barrons.com•14 hours ago
P&G: Not Worth the Gamble
Shares of Procter & Gamble (PG) are tumbling Friday, a day after it reported lackluster organic sales growth guidance, which overshadowed slightly better than expected third-quarter earnings. Argus’ John Staszak downgraded the shares to Hold from Buy, writing that the company’s growth has not increased to the level he expected despite divestitures. Deutsche Bank's Stephen Powers downgraded P&G to Hold from Buy and lowered his price target to $80 from $88.
- CNBC•15 hours ago
Just ask Goldman and P&G: Wall Street doesn't care about your good earnings right now
Goldman Sachs reported first-quarter results that handily beat on both the top and bottom lines, but its stock fell 1.6 percent after the financial report. Consumer giant Procter & Gamble may have faced a similar issue after it reported strong revenues on Thursday. "It's not the earnings beat, look at the revisions, it's the direction of the estimates that move prices," Nick Raich of The Earnings Scout said.
- Zacks•15 hours ago
Why P&G Weighs on Staples ETFs Despite Beating Estimates
Better-than-expected results and a big-ticket acquisition could not save Procter & Gamble stock. Time to stave off from staples ETFs?
Market Realist•16 hours agoWhy PG’s Earnings Dragged KMB, CL, CLX, and CHD Down
Procter & Gamble (PG) reported weak sales and earnings growth in fiscal 3Q18 (period ended March 31, 2018) on April 19, 2018. The company’s stock fell 4.2% after the release and closed at $74.95. Procter & Gamble’s soft organic sales and tepid margin performance sent the stocks of other major CPG (consumer packaged goods) companies down as investors fear that price competition, business reinvestment needs, and inflation in commodities and transportation costs are likely to dent the financials of these companies.
American City Business Journals•16 hours agoP&G targets harsh social media posts with #GoGentle ad campaign
Procter & Gamble Co. has launched an advertising campaign featuring TV and movie star Priyanka Chopra, and the brand ambassador for Pantene shampoo suggests people think twice about making harsh social media posts.
American City Business Journals•18 hours agoP&G resumes advertising on YouTube after 1-year pause
Procter & Gamble Co. began notifying brand teams this week that they can resume advertising on YouTube, the video-sharing website that’s a subsidiary of Google.
- Benzinga•19 hours ago
Argus Cites Disappointing Organic Growth In Procter & Gamble Downgrade
Procter & Gamble Co (NYSE: PG ) reported fiscal third-quarter earnings Thursday that exceeded the Street's expectations but also reaffirmed disappointing organic growth rates, according to Argus. The Analyst ...
- MarketWatch•19 hours ago
Five stocks to put in the trash during spring cleaning
IBM, Home Depot and three other blue-chip companies have been performing poorly. By Jeff Reeves.
- CNBC•19 hours ago
Bank of America downgrades Procter & Gamble on 'longer lasting' challenges
Bank of America Merrill Lynch analysts downgraded Procter & Gamble to neutral from buy and cut their price target on the stock by $8 to $82 a share. The report cited negative price pressures in every segment for the latest quarter, a disproportionate hit to the company from industry destocking and rising costs for consumer packaged goods companies. Bank of America Merrill Lynch downgraded P PG rocter & Gamble PG to neutral from buy, based on the view it will be more difficult than expected for the business to grow.
- CNBC•19 hours ago
Bank of America downgrades Procter & Gamble on 'longer lasting' challenges
Bank of America Merrill Lynch downgraded Procter & Gamble to neutral from buy, based on the view it will be more difficult than expected for the business to grow.
- Motley Fool•19 hours ago
Procter & Gamble Earnings: Market Share Struggles Continue
Here are the highlights from the consumer staples giant's fiscal third-quarter results.
- Market Realist•20 hours ago
What Analysts Recommend for Colgate-Palmolive Stock
Most of the analysts covering Colgate-Palmolive (CL) have maintained “hold” ratings on its stock as a soft sales environment, a moderating category growth rate, increased competition, and margin headwinds have kept them on the sidelines.
- Moody's•20 hours ago
Procter & Gamble International Funding SCA -- Moody's affirms Procter & Gamble's Aa3 rating following announced acquisition of Merck's consumer health business; outlook stable
Moody's Investors Service, ("Moody's") today affirmed the ratings of The Procter & Gamble Company ("P&G"), including its Aa3 senior unsecured rating and Prime-1 short-term rating. This ...
- ACCESSWIRE•20 hours ago
Today’s Research Reports on Stocks to Watch: The Clorox Company and Procter & Gamble
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / The Clorox Company and Procter & Gamble both sank to new lows on Thursday. The Clorox company saw its shares decrease after a downgrade from a Morgan Stanley ...
- Zacks•21 hours ago
Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress
The Dow experienced a particularly volatile week as earnings results took center stage.
- Market Realist•21 hours ago
What Could Pressure Colgate-Palmolive’s 1Q18 Margins?
As for Colgate-Palmolive (CL), the company’s profit margins are likely to be adversely impacted by inflation in commodity prices, including resins and pulp. Higher logistics costs and increased advertising spending to support new product launches and drive market share are also expected to hurt its margins. Higher volumes, a focus on productivity savings, and SKU optimization are likely to support its margins.
- TheStreet.com•22 hours ago
Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business
Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.
- Morningstar•15 hours ago
P&G Not Standing Still, Shares Attractive
The market is punishing P&G again after reporting languishing sales, but we still think the firm can drive longer-term growth.
